GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Liabilities-to-Assets

Instadose Pharma (Instadose Pharma) Liabilities-to-Assets : 0.22 (As of Feb. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Instadose Pharma's Total Liabilities for the quarter that ended in Feb. 2022 was $8.09 Mil. Instadose Pharma's Total Assets for the quarter that ended in Feb. 2022 was $36.14 Mil. Therefore, Instadose Pharma's Liabilities-to-Assets Ratio for the quarter that ended in Feb. 2022 was 0.22.


Instadose Pharma Liabilities-to-Assets Historical Data

The historical data trend for Instadose Pharma's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Liabilities-to-Assets Chart

Instadose Pharma Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21
Liabilities-to-Assets
Get a 7-Day Free Trial 13.00 - - - -

Instadose Pharma Quarterly Data
May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.22

Competitive Comparison of Instadose Pharma's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Instadose Pharma's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instadose Pharma's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instadose Pharma's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Instadose Pharma's Liabilities-to-Assets falls into.



Instadose Pharma Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Instadose Pharma's Liabilities-to-Assets Ratio for the fiscal year that ended in Nov. 2021 is calculated as:

Liabilities-to-Assets (A: Nov. 2021 )=Total Liabilities/Total Assets
=0.165/0
=N/A

Instadose Pharma's Liabilities-to-Assets Ratio for the quarter that ended in Feb. 2022 is calculated as

Liabilities-to-Assets (Q: Feb. 2022 )=Total Liabilities/Total Assets
=8.089/36.142
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Instadose Pharma  (OTCPK:INSD) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Instadose Pharma Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Instadose Pharma (Instadose Pharma) Business Description

Traded in Other Exchanges
N/A
Address
5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6
Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.

Instadose Pharma (Instadose Pharma) Headlines

From GuruFocus